Record Display for the EPA National Library Catalog

RECORD NUMBER: 117 OF 400

OLS Field Name OLS Field Data
Main Title Development document for final effluent limitations guidelines, new source performance standards, and pretreatment standards for the pharmaceutical manufacturing point source category.
Author Hund, F. H.
CORP Author Environmental Protection Agency, Washington, DC. Effluent Guidelines Div.
Publisher U.S. Environmental Protection Agency, Office of Water, Effluent Guidelines Division,
Year Published 1983
Report Number EPA 440/1-83/084
Stock Number PB84-180066
OCLC Number 16959286
Subjects Drug factories--Effluent guidelines. ; Drug factories--Environmental aspects. ; Effluent quality. ; Water--Pollution.
Additional Subjects Water pollution control ; Drug industry ; Regulations ; Guidelines ; Standards ; Sources ; Industrial waste treatment ; Technology ; Cost analysis ; Design criteria ; Technology ; National government ; Pretreatment(Water) ; Water pollution abatement ; Point sources ; Best technology ; New source performance standards
Internet Access
Description Access URL
http://nepis.epa.gov/Exe/ZyPDF.cgi?Dockey=000014OZ.PDF
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
EJAD  EPA 440/1-83-084 Region 3 Library/Philadelphia, PA 09/15/1995
EJBD ARCHIVE EPA 440-1-83-084 Headquarters Library/Washington,DC 11/13/2013
EJBD  EPA 440-1-83-084 Headquarters Library/Washington,DC 10/06/2015
ESAD  EPA 440-1-83-084 Region 10 Library/Seattle,WA 11/08/2017
NTIS  PB84-180066 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. NTIS 01/01/1988
Collation 1 volume (various pagings) : illustrations
Abstract
This document presents the findings of a study of the Pharmaceutical Manufacturing Point Source Category for the purpose of finalizing effluent limitations guidelines for existing and new point sources and to establish pretreatment standards for existing and new dischargers to publicly owned treatment works to implement Sections 301, 303, 306, 307, 308 and 501 of the Clean Water Act. The information presented supports final regulations based on best practicable control technology currently available (BPT) and best available technology (BAT), new source performance standards (NSPS) and pretreatment standards for new and existing sources (CPSNS) and (PSES) for the Pharmaceutical Manufacturing Point Source Category. The report presents and discusses data gathering efforts, consideration of subcategorization, characterization of wastewaters, selection of pollutant parameters, review of treatment technology, cost and non-water quality considerations and development of regulatory options and effluent limitations.
Notes
"September 1983." Includes bibliographical references. Includes glossary.